Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...

A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center ...

Disrupted sleep and shift work may fuel aggressive breast cancer by weakening immunity and altering tissue. New research ...

Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical ...

Scientists identify measurable cellular changes that flag higher cancer risk more than a decade before tumors appear. In A ...

A new study warns that night shifts and irregular sleep schedules may raise the risk of aggressive breast cancer. Researchers ...

An international team of researchers led by the Indian Institute of Technology (IIT) Madras has developed a cutting-edge ...

Ceralasertib in combination with Imfinzi (durvalumab) did not meet the primary endpoint of overall survival (OS) in the phase ...

An international team of scientists led by the Indian Institute of Technology (IIT) Madras has unveiled a novel nanoinjection ...

IIT-M and Australian researchers developed a nanoinjection system for breast cancer. It uses nanotubes to deliver drugs directly to tumors, reducing toxicity and doses while sparing healthy cells.

A new study published today in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center details a therapeutic vulnerability in  patients with an aggressive ...